Gabriella Farina's research works | Azienda Ospedaliera Fatebenefratelli e Oftalmico Milano (Fatebenefratelli) and other places
LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial - ESMO Open
PPT - Gabriella Farina PowerPoint Presentation, free download - ID:1728180
Gabriella Farina | Medici | ASST FBF SACCO
La Rete locale di Cure Palliative di Milano
Diapositiva 1
Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from b
Palliative Sedation in Terminal Cancer Patients Admitted to Hospice or Home Care Programs: Does the Setting Matter? Results From a National Multicenter Observational Study - Journal of Pain and Symptom Management
Nutritional Support in Cancer patients: update of the Italian Intersociety Working Group practical recommendations
Scanned Document
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer
Sabato 7 Aprile corso Unitalsi: "la fine della vita" - CiaoComo
20+ "Gabriella Farina" profiles | LinkedIn
ASST Fatebenefratelli & SACCO | ESMO
Rationale for Treatment and Study Design of TAILOR: A Randomized Phase III Trial of Second-line Erlotinib Versus Docetaxel in the Treatment of Patients Affected by Advanced Non–Small-Cell Lung Cancer With the Absence
The prognostic role of tumor size in early breast cancer in the era of molecular biology | PLOS ONE
Palliative Sedation in Terminal Cancer Patients Admitted to Hospice or Home Care Programs: Does the Setting Matter? Results From a National Multicenter Observational Study - Journal of Pain and Symptom Management
Consiglio di Amministrazione </br> 2016-2019 | Fondazione Aiom
Presentazione standard di PowerPoint
Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of Two Different Escalating Strategies for Pregabalin and Oxycodone Combination Therapy for Neuropathic Pain in Cancer Patients | PLOS ONE
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study∗ - Clinical Breast Cancer
Italian Nivolumab Expanded Access Program in Nonsquamous Non–Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients - Journal of Thoracic Oncology
PDF) The prognostic role of tumor size in early breast cancer in the era of molecular biology | Sheila Piva - Academia.edu
